Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhei Tomita

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 1, 2026
Shuhei Tomita
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 7, 2020
[The effect of PHD inhibitor on tumor microenvironment and tumor immune response]Shinji Matsunaga, Shuhei Tomita
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 1, 2023
[Preface]Yuhei Nishimura, Shuhei Tomita
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|June 27, 2009
[Role of hypoxemia inducible transcription factor in tissue remodeling]Shuhei Tomita, Toshiaki Tamaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Role of interferon for the treatment of myeloma]Shuhei Tomita, Shinichiro Okamoto
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 1, 2024
[The effect of PHD inhibitor on tumor microenvironment and tumor immune response]Shinji Matsunaga, Shuhei Tomita
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 1, 2023
[Devices and attempts to make understand horizontally and vertically for pharmacology education in Osaka Metropolitan University]Shuhei Tomita, Shinji Matsunaga, Takehiro Yamaguchi
Seikagaku. the Journal of Japanese Biochemical Society|May 31, 2013
[Pathophysiological responses to hypoxia in vascular remodeling by hypoxia-inducible factor-1]Shuhei Tomita, Yoshitaka Kihira, Toshiaki Tamaki
Cureus|May 22, 2026
Multimodal Imaging in Indolent Nonprogressive Multifocal Choroidal Lesions: A Case ReportRyota Ando, Shuhei Tomita, Masayo Kimura, et al.
Molecular Medicine Reports|September 29, 2023
Signaling pathways upregulating glutathione‑specific γ‑glutamylcyclotransferase 1 by 3‑(5'‑hydroxymethyl‑2'‑furyl)‑1‑benzylindazoleYoshitaka Kihira, Yoshino Fujimura, Shuhei Tomita, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 1, 2026
Shuhei Tomita
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 7, 2020
[The effect of PHD inhibitor on tumor microenvironment and tumor immune response]Shinji Matsunaga, Shuhei Tomita
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 1, 2023
[Preface]Yuhei Nishimura, Shuhei Tomita
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|June 27, 2009
[Role of hypoxemia inducible transcription factor in tissue remodeling]Shuhei Tomita, Toshiaki Tamaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Role of interferon for the treatment of myeloma]Shuhei Tomita, Shinichiro Okamoto
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 1, 2024
[The effect of PHD inhibitor on tumor microenvironment and tumor immune response]Shinji Matsunaga, Shuhei Tomita
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 1, 2023
[Devices and attempts to make understand horizontally and vertically for pharmacology education in Osaka Metropolitan University]Shuhei Tomita, Shinji Matsunaga, Takehiro Yamaguchi
Seikagaku. the Journal of Japanese Biochemical Society|May 31, 2013
[Pathophysiological responses to hypoxia in vascular remodeling by hypoxia-inducible factor-1]Shuhei Tomita, Yoshitaka Kihira, Toshiaki Tamaki
Cureus|May 22, 2026
Multimodal Imaging in Indolent Nonprogressive Multifocal Choroidal Lesions: A Case ReportRyota Ando, Shuhei Tomita, Masayo Kimura, et al.
Molecular Medicine Reports|September 29, 2023
Signaling pathways upregulating glutathione‑specific γ‑glutamylcyclotransferase 1 by 3‑(5'‑hydroxymethyl‑2'‑furyl)‑1‑benzylindazoleYoshitaka Kihira, Yoshino Fujimura, Shuhei Tomita, et al.
Pageof 12